Halberd Archives - Page 3 of 3 - Halberd Corporation

Nov 25 2020

Halberd Corp. CEO Interviewed on Money TV;
Discusses 2020 Accomplishments and Plans

By Admin|2020-11-24T20:59:01-05:00November 25th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, November 25, 2020 – Halberd Corporation (OTC-PINK: "HALB") Chairman, President and CEO, William A. Hartman, was interviewed this week by host, Donald Baillargeon, on Money TV. Mr. Hartman recapped the company’s accomplishments, describing its most promising technologies and described the unique applications perceived, including a sneak peek at the future. Mr. Hartman ...

Nov 19 2020

Halberd Corporation Files for Patent Protection on Covid-19 Extracorporeal Treatment Variation

By Admin|2020-11-18T19:10:48-05:00November 19th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, November 19, 2020 – Halberd Corp. (OTC PINK: "HALB") reported the filing of a provisional patent application on a variation of Halberd’s patented extracorporeal method to treat/eradicate Covid-19 from a patient’s blood. By using an extracorporeal (outside the body) treatment method, the patient is exposed to far fewer potential negative side effects ...

Nov 12 2020

Halberd Corporation Reveals Patent-Pending Fluorescent Antibody’s Wide Role in Covid-19 Detection & Treatment

By Admin|2020-11-11T20:25:36-05:00November 12th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, November 12, 2020 – Halberd Corporation (OTC PINK: "HALB") today disclosed information on their patent-pending fluorescent anti-Spike protein monoclonal antibodies against Covid-19 developed in conjunction with Dr. Qiang (Shawn) Chen of Arizona State University. The salient feature of Halberd’s new class of antibody is that it fluoresces in the presence of Covid-19 ...

Oct 19 2020

Arizona State University/Halberd Initiate Patent Application for Unique New Engineered Class of Covid-19 Antibody

By Admin|2020-10-19T12:43:39-04:00October 19th, 2020|Featured, Investor News, News|0 Comments

Updated 12:30PM Jackson Center, PA, October 19, 2020 – Halberd Corporation (OTC PINK: "HALB") today announced the creation of a new class of anti-Spike protein monoclonal antibodies against Covid-19. The discovery is the result of Halberd’s research in conjunction with Arizona State University’s Dr. Qiang “Shawn” Chen, utilizing Halberd’s intellectual property created by Mitchel S. ...

Oct 8 2020

Halberd Corporation CEO Update Letter – October, 2020

By Admin|2020-10-07T19:53:21-04:00October 8th, 2020|Featured, Investor News|0 Comments

Greetings From The CEO And Staff At Halberd Corporation! (OTC-PINK: HALB) This initial CEO Letter reflects a summary of major accomplishments since I began my tenure at Halberd Corporation. Going forward, I intend to provide update letters to our shareholders and the public on a quarterly basis. A LOOK BACK Since I began at Halberd ...

Sep 21 2020

Arizona State University/Halberd Corp. Covid-19 Research Program Progress – Successful Covid Spike Protein Disease Antigen Re-Creation!

By Admin|2020-09-20T20:34:28-04:00September 21st, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, September 21, 2020 – Halberd Corporation (OTC PINK: "HALB") released a progress update on the research being conducted in conjunction with Arizona State University researchers. Dr. Qiang Chen, ASU’s lead researcher, reports the successful re-creation of the coronavirus spike protein disease antigen in laboratory research. With this breakthrough, Dr. Chen’s team will ...

Aug 10 2020

Halberd Corporation Adds Dr. Abdon Nanhay to Scientific Advisory Board

By Admin|2020-08-10T08:00:04-04:00August 10th, 2020|Featured, Investor News, News|0 Comments

Furthering the Fight Against Covid-19 Internationally Jackson Center, PA, August 10, 2020 – Halberd Corp. (OTC PINK: "HALB") today confirmed the addition of Dr. Abdon Nanhay as a member of the Scientific Advisory Board. Dr. Nanhay, a Brazilian physician, has over 25 years of experience in health and biological sciences. Dr. Nanhay’s experiences include general ...

Aug 4 2020

Halberd Corporation Secures $2 Million for Covid-19 Research

By Admin|2020-08-04T08:00:29-04:00August 4th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, August 4, 2020 – Halberd Corp. (OTC PINK: "HALB") announced today that they have secured non-dilutive, grant-based funding for their patent pending Covid-19 treatment(s). Newly formed Nonprofit Organization, Epidemiologic Solutions Corporation, a Louisiana, Internal Revenue Code Section 501(c)(3) application pending, has committed to provide funding of approximately $2,000,000, as required by Halberd ...

Jun 9 2020

Halberd Corporation Appoints Dr. Patricio Reyes to Scientific Advisory Board

By Admin|2020-06-21T23:04:50-04:00June 9th, 2020|Featured, News, Technology|0 Comments

Jackson Center, PA, June 9, 2020 – Halberd Corporation (OTC Pink: HALB) announced the appointment of Dr. Patricio F. Reyes to its Scientific Advisory Board effective immediately He will report to Halberd’s Chairman, President and CEO, William A. Hartman. Dr. Reyes, MD, FAAN, a board certified neurologist and neuropathologist, is a Board Member of the ...

Previous 23